SEM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SEM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Bad Debt Percentage of Revenue % can be used to estimate the company’s bad debt value. If the company’s bad debt percentage is from historical data, the metric can be used as an indicator of a company's receivable management ability. Under the requirements of transparency and accuracy, lower Bad Debt Percentage of Revenue is better.
The historical rank and industry rank for Select Medical Holdings's Bad Debt Percentage of Revenue % or its related term are showing as below:
The historical data trend for Select Medical Holdings's Bad Debt Percentage of Revenue % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Select Medical Holdings Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Bad Debt Percentage of Revenue % | Get a 7-Day Free Trial | ||||||||||
Medicare Income Percentage of Revenue % | Get a 7-Day Free Trial | ||||||||||
Medicaid Income Percentage of Revenue % | Get a 7-Day Free Trial | ||||||||||
Managed Care Income Percentage of Revenue % | Get a 7-Day Free Trial |
Select Medical HoldingsQuarterly Data | |||||||||||||||||||||||||||||||||||||||||
Trend | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |||||||||||||||||||||
Bad Debt Percentage of Revenue % | Get a 7-Day Free Trial |
For the Medical Care Facilities subindustry, Select Medical Holdings's Bad Debt Percentage of Revenue %, along with its competitors' market caps and Bad Debt Percentage of Revenue % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Companies usually use Bad Debt Percentage of Revenue % to estimate their bad debt. The initial estimates of a company's bad debt allowance is typically based upon past performance. The formula is:
Bad Debt Percentage of Revenue % | = | ( Uncollectible sales | / | Revenue ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Select Medical Holdings (NYSE:SEM) Bad Debt Percentage of Revenue % Explanation
A bad debt expense is recognized when a receivable is no longer collectible because a customer is unable to fulfill their obligation to pay an outstanding debt due to bankruptcy or other financial problems.
The analysis of bad debt should be combined with the allowance and adjustment the company made of the fiscal year. If the company’s Bad Debt Percentage of Revenue % kept increasing, the company’s profitability should be questioned. However, abnormal low ratios are also worth attention because it may be a sign of fiscal report manipulation.
Thank you for viewing the detailed overview of Select Medical Holdings's Bad Debt Percentage of Revenue % provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert A Ortenzio | director, officer: Chief Executive Officer | 4718 OLD GETTYSBURG RD, POST OFFICE BOX 2034, MECHANICSBURG PA 30309 |
Breighner Robert G. Jr | officer: Vice President, Compliance | C/O SELECT MEDICAL HOLDINGS CORPORATION, 4714 GETTYSBURG ROAD, MACHANICSBURG PA 17055 |
Michael F Malatesta | officer: Senior Vice President, Finance | C/O SELECT MEDICAL CORPORATION, 4714 GETTYSBURG RD, P.O. BOX 2034, MECHANICSBURG PA 17055 |
Christopher Weigl | officer: Chief Accounting Officer | C/O SELECT MEDICAL CORPORATION, 4714 GETTYSBURG ROAD, P.O. BOX 2034, MECHANICSBURG PA 17055 |
David S Chernow | officer: Chief Executive Officer | C/O JUNIOR ACHIEVEMENT INC, ONE EDUCATION WAY, COLORADO SPRINGS CO 80906 |
Parvinderjit S. Khanuja | director | C/O SELECT MEDICAL CORPORATION, 4714 GETTYSBURG RD, P.O. BOX 2034, MECHANICSBURG PA 17055 |
Marilyn B Tavenner | director | 13600 BUTLERS ROAD, AMELIA COURT HOUSE VA 23002 |
Michael E Tarvin | officer: Executive Vice President | 4716 OLD GETTYSBURG ROAD, PO BOX 2034, MECHANICSBURG PA 17055 |
Martin F Jackson | officer: Executive Vice President | 4716 OLD GETTYSBURG ROAD, PO BOX 2034, MECHANICSBURG PA 17055 |
Katherine R Davisson | director | C/O SELECT MEDICAL CORPORATION, 4714 GETTYSBURG ROAD, P.O. BOX 2034, MECHANICSBURG PA 17055 |
Ely James S. Iii | director | 4000 MERIDIAN BLVD, FRANKLIN TN 37067 |
Scott A Romberger | officer: Senior Vice President | 4716 OLD GETTYSBURG ROAD, PO BOX 2034, MECHANICSBURG PA 17055 |
Thomas P Mullin | officer: Executive Vice President | C/O SELECT MEDICAL CORPORATION, 4714 GETTYSBURG ROAD, P.O. BOX 2034, MECHANICSBURG PA 17055 |
Leopold Swergold | director | |
Daniel Thomas | director | C/O SELECT MEDICAL CORPORATION, 4714 GETTYSBURG ROAD P.O. BOX 2034, MECHANICSBURG PA 17055 |
From GuruFocus
By PRNewswire PRNewswire • 03-31-2022
By PRNewswire • 01-22-2024
By PRNewswire PRNewswire • 07-26-2022
By PRNewswire PRNewswire • 07-13-2022
By PRNewswire PRNewswire • 04-06-2022
By PRNewswire PRNewswire • 07-03-2022
By GuruFocus Research • 09-12-2023
By PRNewswire PRNewswire • 07-26-2022
By PRNewswire PRNewswire • 11-02-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.